Why other provinces may follow Ontario’s lead in reducing physician fees LETTER: OMA failing doctors in fight with province ARB linked to GI symptoms Practice Issues: Adverse Reactions - Dabigatran: risk of ischemic events Two recent papers examined the risk of ischemic events associated with dabigatran. Practice Issues: Ethics and Issues Are pharmacists overusing specialist titles? Openers: Have your say The move toward tech regulation is consistent with the broader objective of expanding pharmacists’ scope of practice. Spotlight: UBC's Peter Zed As the first associate dean of practice innovation, pharmacist’s job is to bridge the divide between practice and academia. Openers: CADTH Corner Uncharted territory for those with schizophrenia. Practice Issues: Adverse Reactions - Aliskiren not recommended with an ACEI or ARB Research finds combination results in higher incidence of nonfatal strokes, renal complications, hyperkalemia, and hypotension. Editorial: The most wonderful time of the year For those of us with an interest in pharmacy on a national level, spring means conference season! First Previous 1299 1300 1301 1302 1303 Next Last
